Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05254574 · ClinicalTrials.gov registry record · Phase 1
Sustained Acoustic Medicine for Osteoarthritis Pain
A Phase 1 study of Osteoarthritis, sponsored by ZetrOZ.
- Recruiting
- Registry status
- Phase 1
- Development phase
- 200
- Enrollment target
- 1
- Study location
NCT05254574: Recruiting Phase 1 study of Osteoarthritis, sponsored by ZetrOZ.
NCT05254574 is a Phase 1 study of Osteoarthritis that is actively recruiting participants, run by ZetrOZ. The registered enrollment target is 200 participants, below the 816-participant average among 135 other Osteoarthritis trials with a reported enrollment target (75% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05254574, a Phase 1 study of Osteoarthritis, is actively recruiting participants, sponsored by ZetrOZ.
- RECRUITING
- Registry status
- Phase 1
- Development phase
- 200 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to compare Sustained Acoustic Medicine treatment to topical pain relief gel for the symptomatic management of osteoarthritis. The study will measure pain and function scores for patients undergoing treatment.
Primary Outcome
Change in the self described pain units on a scale by patient at baseline and post-
Conditions Studied
Interventions
- DEVICE Sustained Acoustic Device with 2.5% Diclofenac Patch
- DRUG 2.5% Diclofenac Patches
Study Locations (1)
Florida
- James A Haley Veterans Hospital - Tampa
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 200 participants |
| Start Date | 2022-02-14 |
| Est. Completion | 2026-05-31 |
| Phase | Phase 1 |
What NCT05254574 shows while recruiting
NCT05254574 is an interventional study that assigns participants to a tested intervention. The registered 200 participants enrollment target is mid-sized for trials with a published cap, below the 816-participant average among 135 other Osteoarthritis trials with a reported enrollment target (75% lower).
The record links to 1 condition, with Osteoarthritis appearing as the primary indexed condition, and to 2 interventions - of which Sustained Acoustic Device with 2.5% Diclofenac Patch is the first listed.
NCT05254574 reports a single indexed study location in Florida.
Frequently Asked Questions
What is clinical trial NCT05254574 about?
NCT05254574 is a clinical study titled "Sustained Acoustic Medicine for Osteoarthritis Pain". The purpose of this study is to compare Sustained Acoustic Medicine treatment to topical pain relief gel for the symptomatic management of osteoarthritis. The study will measure pain and function scores for patients undergoing treatment.
What is the current status of trial NCT05254574?
This trial is currently recruiting. It is a Phase 1 study. The enrollment target is 200 participants. The study started on 2022-02-14. Estimated completion is 2026-05-31.
What conditions does trial NCT05254574 study?
This clinical trial studies the following conditions: Osteoarthritis.
What interventions are being tested in trial NCT05254574?
The interventions under investigation include: Sustained Acoustic Device with 2.5% Diclofenac Patch (DEVICE), 2.5% Diclofenac Patches (DRUG).
Who is sponsoring clinical trial NCT05254574?
This trial is sponsored by ZetrOZ, which has 17 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05254574 being conducted?
This trial has 1 study location across Florida. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Osteoarthritis
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT05254574's enrollment target sits among peer trials
200 57th of 135 higher than 75 of 135 other Osteoarthritis trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Osteoarthritis trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
A Study With GLPG1972 in Osteoarthritis Subjects
COMPLETED · Phase 1
-
Autologous Alpha-2 Macroglobulin Rich Plasma, Safety and Efficacy in Symptomatic Moderate Knee Osteoarthritis
COMPLETED · Phase 1
-
Translating Metabolic Responses to Mechanical Insult Into Early Interventions to Prevent PTOA
COMPLETED · Phase 1
-
Safety & Effectiveness of Autologous Regenerative Cell Therapy on Pain & Inflammation of Osteoarthritis of the Knee
RECRUITING · Phase 2
-
A Prospective, Post-Market, Clinical Follow-up Study of the Incompass™ Total Ankle System
RECRUITING
-
Reliability of Pupil Response to Acute Pain
RECRUITING
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00107289 · 200 participants · Phase 2
Iodine I 131 Metaiodobenzylguanidine in Treating Patients With Recurrent, Progressive, or Refractory Neuroblastoma or Malignant Pheochromocytoma or Paraganglioma
- NCT00109174 · 200 participants · NA
MRS Measurement of Glutamate and GABA Metabolism in Brain
- NCT00177268 · 200 participants
Blood, Urine, and Tissue Collection for Cutaneous Lymphoma, Eczema, and Atopic Dermatitis Research
- NCT00493688 · 200 participants
A Study to Determine Whether Perioperative Energy Dynamics Correlates With Postoperative Outcomes
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI